Table 1.
Polymyxin lipopeptide |
Polymyxin lipopeptide sequence | KD (µM) |
---|---|---|
Colistin | Octanoyl-Dab-Thr-Dab-Dab*-Dab-D-Leu-Leu-Dab-Dab-Thr* | 0.56 |
Polymyxin B | Octanoyl-Dab-Thr-Dab-Dab*-Dab-D-Phe-Leu-Dab-Dab-Thr* | 0.26 |
FADDI-019 | Octanoyl-Dab-Thr-Dab-Dab*-Dab-D-OctGly-Leu-Dab-Dab-Thr* | 0.43 |
FADDI-020 | 4-Biphenylcarboxyl-Dab-Thr-Dab-Dab*-Dab-D-OctGly-Leu-Dab-Dab-Thr* | 0.94 |
FADDI-043 | Dansylgly-OctGly-Dab-Thr-Dab-Dab*-Dab-D-Phe-Leu-Dab-Dab-Thr* | 2.71 |
FADDI-063 | Octanoyl-Dab-Thr-Dab-Dab*-Dab-D-Phe-Cys(Bz)-Dab-Dab-Thr* | 5.15 |
FADDI-187 | 4-tert-Butylphenylacetyl-D-Dab-Dab*-Dab-D-Phe-Leu-Dab-Dab-Thr* | 5.39 |
FADDI-053 | Dansylgly-Dab-Thr-Dab-Dab*-Dab-D-Phe-Leu-Dab-Dab-Thr* | 5.50 |
FADDI-206 | Octanoyl-Dab-Thr-Dab-Dab*-Dab-D-Phe-Met-Dab-Dab-Thr* | 8.80 |
FADDI-065 | Octanoyl-Dab-Thr-Lys-Dab*-Dab-D-Phe-Leu-Dab-Dab-Thr* | 13.1 |
FADDI-207 | Octanoyl-Dab-Thr-Dab-Dab*-Dab-D-Met-Leu-Dab-Dab-Thr* | 13.4 |
FADDI-180 | Octanoyl-Dab-Thr-Pro-Dab*-Dab-D-Phe-Leu-Dab-Dab-Thr* | 20.3 |
FADDI-167 | Octanoyl-Dab-Thr-Dab-Dab*-Dab-D-Phe-Leu-Ala-Dab-Thr* | NSB |
FADDI-168 | Octanoyl-Dab-Thr-Dab-Dab*-Dab-D-Phe-Leu-Asn-Dab-Thr* | NSB |
FADDI-169 | Octanoyl-Dab-Thr-Dab-Dab*-Dab-D-Phe-Leu-Thr-Dab-Thr* | NSB |
FADDI-170 | Octanoyl-Dab-Thr-Dab-Dab*-Dab-D-Phe-Leu-Dab-Ala-Thr* | NSB |
FADDI-171 | Octanoyl-Dab-Thr-Dab-Dab*-Dab-D-Phe-Leu-Dab-Asn-Thr* | NSB |
FADDI-172 | Octanoyl-Dab-Thr-Dab-Dab*-Dab-D-Phe-Leu-Dab-Thr-Thr* | NSB |
FADDI-175 | Octanoyl-Dab-Thr-Dab-Dab*-Ala-D-Phe-Leu-Dab-Dab-Thr* | NSB |
FADDI-176 | Octanoyl-Dab-Thr-Dab-Dab*-Asn-D-Phe-Leu-Dab-Dab-Thr* | NSB |
FADDI-177 | Octanoyl-Dab-Thr-Dab-Dab*-Thr-D-Phe-Leu-Dab-Dab-Thr* | NSB |
Colistin nonapeptide |
Thr-Dab-Dab*-Dab-D-Leu-Leu-Dab-Dab-Thr* | NSB |
NSB. No significant binding (KD>25 µM)
Cyclisation points